Pharmaceuticals for the Miraflores Clinic

This tender concerns the procurement of pharmaceuticals for the Miraflores Clinic. The objective is to acquire a range of essential medicines and medical supplies to ensure the clinic can provide adequate healthcare services to its patients. The scope of this acquisition is expected to include various categories of drugs, such as antibiotics, analgesics, anti-inflammatories, cardiovascular medications, and other therapeutic agents, as well as potentially over-the-counter (OTC) products and medical consumables. The specific list of required pharmaceuticals, including their dosages, forms (e.g., tablets, capsules, injections), quantities, and required shelf life, will be detailed in the tender documents. This procurement is critical for the operational continuity and quality of care at the Miraflores Clinic. Bidders are expected to be licensed pharmaceutical suppliers or manufacturers with a proven ability to supply high-quality, authentic medications that comply with all relevant national and international pharmaceutical regulations and standards. The evaluation criteria will likely prioritize product quality, compliance with pharmacopeial standards, competitive pricing, reliability of supply, delivery timelines, and adherence to cold chain requirements where applicable. The successful bidder will play a key role in supporting the health and well-being of the community served by the clinic.

This is a consulting contract in the health and medical services, Monitoring Evaluation and general supplies sectors. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for consulting in the health and medical services sector. Consulting assignments are typically evaluated with a strong emphasis on the technical proposal, including the methodology and qualifications of key experts. Shortlisted firms may be invited to submit financial proposals in a second stage. This contract has already been awarded. The information is published for transparency and market intelligence purposes.